Table 3.
Correlation analysis between PCT and demographics and clinical parameters of CDI patients.
| Parameter | N | PCT level [ng/ml] mean | p-Value |
|---|---|---|---|
| Age (year) | 54 | 3.6 | 0.5512 |
| Gender | |||
| Male | 21 | 2.9 | |
| Female | 33 | 4 | 0.4647 |
| Toxicity | |||
| Toxin A | 6 | 0.3 | |
| Toxin B | 14 | 10.9 | 0.0768 |
| A+B | 34 | 1.2 | |
| Infection acquisition | |||
| Nosocomial | 37 | 1.1 | |
| Community | 17 | 8.9 | 0.0345 |
| Metronidazole Susceptibility | |||
| Susceptible | 44 | 4.3 | |
| Resistant | 10 | 0.6 | 0.6106 |
| Vancomycin susceptibility | |||
| Susceptible | 52 | 3.7 | |
| Resistant | 2 | 1.5 | 0.3073 |
| In hospital mortality | |||
| Alive | 39 | 0.6 | |
| Died | 15 | 11.2 | 0.0002 |
| Lab Parameters | |||
| WBC [cells/μl] | 54 | 3.6 | 0.0190 |
| CRP [mg/l]* | 54 | 3.6 | 0.1651 |
| Albumin [g/dl] | 54 | 3.6 | 0.4434 |
| Creatinine [mg/dl] | 54 | 3.6 | 0.0842 |
∗CRP > 100 was considered = 100. Bold values indicate statistical significance,p-value < 0.05.